The forum "SoHO and Advanced Therapies: From Human to Human," will explore current trends in cell- and gene-based therapies, focusing on substances of human origin (SoHO) intended for human application. Discussions will encompass regulations, manufacturing challenges, and quality aspects.
The event begins with a conference on regulatory perspectives from agencies, represented by their Belgian "Administrateur Général." Two subsequent sessions will delve into manufacturing, engineering, and quality aspects of cell-based therapy (autologous, allogenic, and new iPS platform) and gene therapy. An introduction to challenges in exosomes-based therapy, using the first approved study in the EU as a case study, will also be featured.
The day concludes with a visit to Catalent and a networking cocktail on the exhibition floor.
Let’s discuss the latest in cell therapy advancements, regulatory insights, and quality considerations.
The workflows are extremely versatile. Additionally, since the app is compatible with both tablets and computers, MyCellHub digitizes any workflow in manufacturing, material reception, quality control, or maintenance.
Get up and running quickly by starting from our library of standard unit operations. Make use of MyCellHub’s smart workflow configuration to anticipate variations in process executions.